HPV Vaccine undergoes successful heat stabilization

Cold Chain IQ

A late-stage biopharmaceutical company developing products in inflammation, oncology and biodefense, has recently published data demonstrating a heat stable vaccine formulation of a human papillomavirus (HPV) vaccine. [eventPDF]The work was conducted at the University of Colorado, Boulder by Drs. Randolph and Garcea and demonstrated the successful conversion of a commercial virus-like particle (VLP) based vaccine requiring cold-chain storage to a subunit, alum-adjuvanted, vaccine which is stabl...
To continue reading this story get free access